The Patent Finder
US

Transposition-Based Therapies

US 11,542,528 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Saliogen Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends May 4, 2041 · High confidence

Filed Feb 11, 2022 as application 17/669,939 · Granted Jan 3, 2023
Base term, 20 years from filing
Today
20 years from filing
2021 2041
Clock starts
May 4, 2021
Term ends
May 4, 2041
Granted
Jan 3, 2023
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 4, 2021, when application PCT/US2021/030729, the earliest non-provisional in its chain, was filed (this one was filed Feb 11, 2022)May 4, 2041High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 4, 2041High confidence

This family

Application PCT/US2021/030729PCT application
no patent term
no patent term
US 11,542,528this patent
May 2041
May 2041
Application 18/058,486Pending
not computed
not computed
US 11,993,784In force
May 2041
May 2041
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 9, 2022
Reel 60146, frame 228
Higgins, Joseph J.; Tabibiazar, RaySaliogen Therapeutics, Inc.Assignment of Assignor's Interest
Jun 9, 2022
Reel 60146, frame 234
McMillan, ScottSaliogen Therapeutics, Inc.Assignment of Assignor's Interest
Feb 13, 2026
Reel 73782, frame 606
Saliogen Therapeutics, Inc.Blue Marlin Therapeutics, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited